Literature DB >> 8845350

Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: implications for receptor binding and synthetic vaccine design.

A P Campbell1, C McInnes, R S Hodges, B D Sykes.   

Abstract

The solution structures of peptide antigens from the receptor binding domains of Pseudomonas aeruginosa strains PAO and KB7 have been determined using two-dimensional 1H NMR techniques. Ensembles of solution conformations for the trans forms of these 17-residue disulfide-bridged peptides have been generated using a simulated annealing procedure in conjunction with distance and torsion angle restraints derived from NMR data. Comparison of the NMR-derived solution structures of the PAO and KB7 peptides, with that previously determined (McInnes et al., 1993) and herein refined for the PAK peptide reveals a common structural motif. All three peptide structures contain a type I beta-turn in the conserved sequence Asp134-X-X-Phe137 and a type II beta-turn in the conserved sequence Pro139-X-Gly-Cys142. However, the overall folds of the three peptides differ as well as the disposition of the side chains comprising the hydrophobic pockets. The similarities and differences between the structures of the three strains which bind to a common cell surface receptor are discussed in light of their contributions to synthetic vaccine design.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8845350     DOI: 10.1021/bi00050a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Assembly of a polytopic membrane protein structure from the solution structures of overlapping peptide fragments of bacteriorhodopsin.

Authors:  M Katragadda; J L Alderfer; P L Yeagle
Journal:  Biophys J       Date:  2001-08       Impact factor: 4.033

2.  Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody.

Authors:  Ki Joon Cho; Bert Schepens; Kristof Moonens; Lei Deng; Walter Fiers; Han Remaut; Xavier Saelens
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

3.  Single-residue changes in the C-terminal disulfide-bonded loop of the Pseudomonas aeruginosa type IV pilin influence pilus assembly and twitching motility.

Authors:  Hanjeong Harvey; Marc Habash; Francisca Aidoo; Lori L Burrows
Journal:  J Bacteriol       Date:  2009-08-28       Impact factor: 3.490

4.  Pilin C-terminal peptide binds asialo-GM1 in liposomes: a 2H-NMR study.

Authors:  D H Jones; R S Hodges; K R Barber; C W Grant
Journal:  Protein Sci       Date:  1997-11       Impact factor: 6.725

5.  Structural studies of N-terminal mutants of connexin 32 using (1)H NMR spectroscopy.

Authors:  B D Kalmatsky; Y Batir; T A Bargiello; T L Dowd
Journal:  Arch Biochem Biophys       Date:  2012-06-14       Impact factor: 4.013

6.  Assignments of 1H and 15N resonances of the Pseudomonas aeruginosa K122-4 pilin monomer.

Authors:  D W Keizer; M Kalisiak; M P Crump; J Y Suh; R T Irvin; B D Sykes
Journal:  J Biomol NMR       Date:  2001-04       Impact factor: 2.835

7.  Backbone dynamics of a bacterially expressed peptide from the receptor binding domain of Pseudomonas aeruginosa pilin strain PAK from heteronuclear 1H-15N NMR spectroscopy.

Authors:  A P Campbell; L Spyracopoulos; R T Irvin; B D Sykes
Journal:  J Biomol NMR       Date:  2000-07       Impact factor: 2.835

8.  Solution structure of Compstatin, a potent complement inhibitor.

Authors:  D Morikis; N Assa-Munt; A Sahu; J D Lambris
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

9.  Synthetic peptide vaccine development: designing dual epitopes into a single pilin peptide immunogen generates antibody cross-reactivity between two strains of Pseudomonas aeruginosa.

Authors:  Clifton Hackbarth; Robert S Hodges
Journal:  Chem Biol Drug Des       Date:  2010-08-30       Impact factor: 2.817

10.  Advantages of a synthetic peptide immunogen over a protein immunogen in the development of an anti-pilus vaccine for Pseudomonas aeruginosa.

Authors:  Daniel J Kao; Robert S Hodges
Journal:  Chem Biol Drug Des       Date:  2009-07       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.